Author Archive: Jeremy Parkinson
ISM Non-Manufacturing PMI Beats With 54.5 – USD Extends Gains
The US services sector is doing better than expected: the ISM PMI shows a score of 54.5 points. Among the components, the employment sector returns to expansionary territory with 50.3 points, new orders are up to 56.7 and prices paid are up to 49.1 points. So, prices are still falling, but at a slower pace. The […]
E Unprecedented Transparency
Unprecedented Transparency Unprecedented transparency into offshore tax-haven activities have a few ramifications beyond the obvious money laundering or semi-legal funding of holdings (if disclosed to tax authorities, at least as relates to US law). One might be the global expose of troves concealing funds (that makes popular news; like the FOP’s (Friends of Putin) often […]
E The Daily Shot And Data – April 5, 2016
Greetings, Let’s begin with a few developments in Japan. 1. Dollar-yen fell below 111 as the yen continues to strengthen. Source: barchart This is in spite of the BoJ suggesting that the central bank could push rates deeper into negative territory. Source: MarketWatch 2. Here is the Nikkei 225 response to the yen strengthening, Source: […]
Valeant Stock Soars After Its Own Board Clears Itself Of Any More Wrongdoing, Will File 10-K
Valeant may be on the verge of a technical default as its lender demand not one but two pounds of flesh, it may be suffering imploding sales, it may have fired the entire salesforce for the female libido drug Addyi (which it acquired late last year), and it may be trying to pin all of its allegedly criminal book-cooking […]
Healthcare Revisited
Regarding the recent posts on Healthcare, I took the profit on PFE [edit: AMGN targets higher but taking that profit too] for two reasons; 1) As noted in NFTRH 389 I have a desire to raise cash levels and 2) I watched the most disgusting documentary on Sunday called American Addict. It was a sobering look at the grift if […]
Risk Appetite Wanes As Yen Strengthens
The markets started the day with a risk off mood prevailing strongly across the global markets. In Asia, the Nikkei225 closed down 2.42% while the Shanghai Composite managed to gain 1.46%. Despite Japan’s average cash earnings rising 0.90%, more than the forecasted 0.20%, it did little to help sentiment as the yen continued to firm […]
King Dollar/Yen Could Break Down, Send Risk Off Message To Stocks
Sometimes currency price action can be very helpful, when it comes to whether one should own stocks or not. The US$/Yen has been correlated with stocks fairly well over the past few years. As the US$/YEN was hitting highs over the past year, stocks followed right along with it. Potential is in play, that the […]
S&P 500 Shorts Aren’t Covered Yet; Short Squeeze Could Continue
It’s no secret that we saw the mother of all short squeezes earlier this year, but JPMorgan analysts say all S&P 500 shorts haven’t been covered yet. In fact, they note that the number of shares of companies in the index that are being sold short remains at about the same level it was at in the […]
E Soybeans Fail Their First Test Of $9.20
Here is the chart; Bulls pushed the price past that key level and actually into a seven month high today but that was before the export numbers hit the wires. Those were miserable; just like that they reversed course. Two things are at work here. First is the continued wet weather in the Delta. More […]
Diffusion Pharmaceuticals Takes Aim At Brain Cancer: CEO David Kalergis
It takes extraordinary dexterity to execute a strategic merger, and then to take first steps toward positioning a new molecular entity for a Phase 3 drug trial and potential partnership with a big pharma. That’s exactly the inflection point at which Diffusion Pharmaceuticals Inc. finds itself, says CEO David Kalergis. In this interview with The Life […]
